===== phenotype 0=================================================================
proportion of pts: 0.182467274891
lambda: 11256.637976
----------------------------------------
Disorders of lipoid metabolism	0.217
Hypertensive disease	0.199
Diabetes	0.173
Symptoms involving respiratory system and other chest symptoms	0.148
Ischemic heart disease	0.138
Disorders of the eye and adnexa	0.125
----------------------------------------
Cyclooxygenase Inhibitors	0.143
Anti-Inflammatory Agents, Non-Steroidal	0.135
Antipyretics	0.131
Antihypertensive Agents	0.127
Fibrinolytic Agents	0.120
Platelet Aggregation Inhibitors	0.120
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.113
Anticholesteremic Agents	0.110
===== phenotype 43=================================================================
proportion of pts: 0.17215390718
lambda: 10301.5021304
----------------------------------------
Range name na	0.140
Hypertensive disease	0.136
General symptoms	0.135
Disorders of the eye and adnexa	0.130
Disorders of lipoid metabolism	0.129
Other forms of heart disease	0.112
Diseases of arteries, arterioles, and capillaries	0.111
Ischemic heart disease	0.106
----------------------------------------
Vasodilator Agents	0.153
Antihypertensive Agents	0.147
Antipyretics	0.137
Anti-Arrhythmia Agents	0.122
Calcium Channel Blockers	0.115
Platelet Aggregation Inhibitors	0.114
Fibrinolytic Agents	0.113
Diuretics	0.099
===== phenotype 46=================================================================
proportion of pts: 0.16144387148
lambda: 9694.12836862
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.222
Arthropathies and related disorders	0.132
Hypertensive disease	0.128
Neoplasm of uncertain behavior of other sites & tissues	0.119
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.109
Nutritional deficiencies	0.102
Malignant neoplasm of skin	0.096
Other inflammatory conditions of skin and subcutaneous tissue	0.092
----------------------------------------
Antihypertensive Agents	0.118
Antipyretics	0.117
Platelet Aggregation Inhibitors	0.116
Cyclooxygenase Inhibitors	0.113
Anti-Inflammatory Agents, Non-Steroidal	0.113
Fibrinolytic Agents	0.112
Anticholesteremic Agents	0.106
Vasodilator Agents	0.103
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.102
===== phenotype 25=================================================================
proportion of pts: 0.177707259024
lambda: 9582.4163102
----------------------------------------
Hypertensive disease	0.164
Disorders of lipoid metabolism	0.144
Rheumatism, excluding the back	0.131
Dorsopathies	0.121
Range name na	0.120
Arthropathies and related disorders	0.116
General symptoms	0.113
Diabetes	0.091
----------------------------------------
Anticholesteremic Agents	0.154
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.153
Serotonin Uptake Inhibitors	0.140
Antidepressive Agents, Tricyclic	0.127
Muscle Relaxants, Central	0.120
Antidepressive Agents, Second-Generation	0.107
Antidepressive Agents	0.101
Adrenergic Uptake Inhibitors	0.098
===== phenotype 12=================================================================
proportion of pts: 0.166997223324
lambda: 9397.99595961
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.134
Diseases of esophagus, stomach, and duodenum	0.133
Disorders of lipoid metabolism	0.133
Hypertensive disease	0.127
Dorsopathies	0.124
Arthropathies and related disorders	0.119
Ischemic heart disease	0.116
Other symptoms involving abdomen and pelvis	0.113
----------------------------------------
Cyclooxygenase Inhibitors	0.180
Anti-Inflammatory Agents, Non-Steroidal	0.168
Antipyretics	0.155
Platelet Aggregation Inhibitors	0.144
Fibrinolytic Agents	0.143
Vitamins	0.109
Bone Density Conservation Agents	0.100
===== phenotype 10=================================================================
proportion of pts: 0.163427211424
lambda: 9336.27860654
----------------------------------------
Hypertensive disease	0.153
Range name na	0.144
Disorders of lipoid metabolism	0.140
Diseases of male genital organs	0.128
Nonspecific findings on examination of blood	0.118
Other forms of heart disease	0.113
Symptoms involving urinary system	0.110
Dorsopathies	0.095
----------------------------------------
Cyclooxygenase Inhibitors	0.145
Anti-Inflammatory Agents, Non-Steroidal	0.141
Antihypertensive Agents	0.139
Vasodilator Agents	0.136
Antipyretics	0.127
Fibrinolytic Agents	0.110
Platelet Aggregation Inhibitors	0.109
Calcium Channel Blockers	0.094
===== phenotype 9=================================================================
proportion of pts: 0.167790559302
lambda: 9010.17806217
----------------------------------------
Rheumatism, excluding the back	0.156
Range name na	0.140
Hypertensive disease	0.127
Other diseases of urinary system	0.122
Disorders of lipoid metabolism	0.121
Diabetes	0.114
Disorders of the peripheral nervous system	0.110
Arthropathies and related disorders	0.110
----------------------------------------
Cyclooxygenase Inhibitors	0.182
Anti-Inflammatory Agents, Non-Steroidal	0.167
Antipyretics	0.164
Fibrinolytic Agents	0.146
Platelet Aggregation Inhibitors	0.145
Vitamins	0.100
Anti-Bacterial Agents	0.098
===== phenotype 28=================================================================
proportion of pts: 0.176120587069
lambda: 8789.4184399
----------------------------------------
Hypertensive disease	0.168
Disorders of lipoid metabolism	0.158
Symptoms involving respiratory system and other chest symptoms	0.138
Diabetes	0.116
General symptoms	0.112
Range name na	0.106
Chronic obstructive pulmonary disease and allied conditions	0.105
Other diseases of the upper respiratory tract	0.098
----------------------------------------
Anti-Inflammatory Agents	0.177
Bronchodilator Agents	0.158
Anti-Allergic Agents	0.151
Dermatologic Agents	0.150
Histamine H1 Antagonists, Non-Sedating	0.135
Glucocorticoids	0.121
Tocolytic Agents	0.109
===== phenotype 31=================================================================
proportion of pts: 0.184053946846
lambda: 8649.88070321
----------------------------------------
Hypertensive disease	0.188
Disorders of lipoid metabolism	0.163
Range name na	0.145
Symptoms involving respiratory system and other chest symptoms	0.137
Arthropathies and related disorders	0.133
General symptoms	0.126
Ischemic heart disease	0.108
----------------------------------------
Sympatholytics	0.229
Adrenergic beta-1 Receptor Antagonists	0.204
Anti-Arrhythmia Agents	0.158
Angiotensin-Converting Enzyme Inhibitors	0.150
Cardiotonic Agents	0.136
Calcium Channel Blockers	0.124
===== phenotype 44=================================================================
proportion of pts: 0.178897262991
lambda: 8565.45365235
----------------------------------------
Ischemic heart disease	0.198
Disorders of lipoid metabolism	0.169
Hypertensive disease	0.168
Symptoms involving respiratory system and other chest symptoms	0.168
Other forms of heart disease	0.148
Range name na	0.148
----------------------------------------
Anticholesteremic Agents	0.187
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.178
Explosive Agents	0.138
Hypolipidemic Agents	0.135
Fibrinolytic Agents	0.131
Analgesics, Non-Narcotic	0.116
Platelet Aggregation Inhibitors	0.115
===== phenotype 24=================================================================
proportion of pts: 0.185243950813
lambda: 8537.06788411
----------------------------------------
Hypertensive disease	0.169
Acute respiratory infections	0.164
Arthropathies and related disorders	0.149
Rheumatism, excluding the back	0.144
Disorders of lipoid metabolism	0.143
Diseases of the ear and mastoid process	0.122
Other diseases of the upper respiratory tract	0.109
----------------------------------------
Antihypertensive Agents	0.182
Anti-Allergic Agents	0.153
Anti-Inflammatory Agents	0.141
Bronchodilator Agents	0.138
Calcium Channel Blockers	0.138
Anti-Inflammatory Agents, Non-Steroidal	0.133
Histamine H1 Antagonists, Non-Sedating	0.116
===== phenotype 48=================================================================
proportion of pts: 0.13605712019
lambda: 8236.90454816
----------------------------------------
Hypertensive disease	0.196
Disorders of lipoid metabolism	0.190
Range name na	0.184
Arthropathies and related disorders	0.183
Rheumatism, excluding the back	0.139
General symptoms	0.109
----------------------------------------
Antirheumatic Agents	0.150
Antimetabolites, Antineoplastic	0.128
Enzyme Inhibitors	0.125
Nucleic Acid Synthesis Inhibitors	0.121
Folic Acid Antagonists	0.121
Immunosuppressive Agents	0.121
Abortifacient Agents, Nonsteroidal	0.120
Dermatologic Agents	0.113
===== phenotype 33=================================================================
proportion of pts: 0.166600555335
lambda: 7916.45109747
----------------------------------------
Disorders of lipoid metabolism	0.179
Diabetes	0.165
Organic sleep disorders	0.157
Hypertensive disease	0.156
Symptoms involving skin and other integumentary tissue	0.120
Na	0.116
Mycoses	0.107
----------------------------------------
Antihypertensive Agents	0.142
Anticholesteremic Agents	0.133
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.127
Anti-Inflammatory Agents, Non-Steroidal	0.125
Angiotensin-Converting Enzyme Inhibitors	0.125
Platelet Aggregation Inhibitors	0.119
Fibrinolytic Agents	0.116
Cardiotonic Agents	0.112
===== phenotype 42=================================================================
proportion of pts: 0.149543831813
lambda: 7450.89504011
----------------------------------------
General symptoms	0.223
Range name na	0.184
Hypertensive disease	0.183
Rheumatism, excluding the back	0.158
Arthropathies and related disorders	0.127
Disorders of the eye and adnexa	0.125
----------------------------------------
Cyclooxygenase Inhibitors	0.150
Anti-Inflammatory Agents, Non-Steroidal	0.146
Antihypertensive Agents	0.144
Antipyretics	0.123
Fibrinolytic Agents	0.114
Platelet Aggregation Inhibitors	0.113
Diuretics	0.111
Sodium Chloride Symporter Inhibitors	0.100
===== phenotype 6=================================================================
proportion of pts: 0.168980563269
lambda: 7395.03387712
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.158
Hypertensive disease	0.131
Other diseases of intestines and peritoneum	0.129
Other symptoms involving abdomen and pelvis	0.126
Symptoms involving digestive system	0.122
Anemias	0.118
Symptoms involving respiratory system and other chest symptoms	0.117
Disorders of lipoid metabolism	0.100
----------------------------------------
Anti-Ulcer Agents	0.189
Proton Pump Inhibitors	0.174
Hypnotics and Sedatives	0.136
Analgesics, Opioid	0.130
Analgesics, Non-Narcotic	0.127
Narcotics	0.126
Anti-Anxiety Agents	0.118
===== phenotype 2=================================================================
proportion of pts: 0.163030543435
lambda: 7380.24939018
----------------------------------------
Hypertensive disease	0.167
Symptoms involving respiratory system and other chest symptoms	0.163
Diabetes	0.163
Disorders of lipoid metabolism	0.145
Range name na	0.138
Ischemic heart disease	0.121
Other diseases of respiratory system	0.101
----------------------------------------
Antiemetics	0.153
Hypnotics and Sedatives	0.130
Anti-Anxiety Agents	0.128
Histamine H1 Antagonists	0.123
GABA Modulators	0.123
Hypoglycemic Agents	0.120
Antipruritics	0.113
Bronchodilator Agents	0.109
===== phenotype 3=================================================================
proportion of pts: 0.165410551369
lambda: 7270.29296382
----------------------------------------
Other diseases of urinary system	0.157
Symptoms involving urinary system	0.142
Symptoms involving respiratory system and other chest symptoms	0.134
Range name na	0.120
Hypertensive disease	0.117
Symptoms involving skin and other integumentary tissue	0.117
Dorsopathies	0.112
Other symptoms involving abdomen and pelvis	0.101
----------------------------------------
Antihypertensive Agents	0.201
Calcium Channel Blockers	0.183
Anti-Arrhythmia Agents	0.154
Analgesics	0.121
Serotonin Uptake Inhibitors	0.119
Anti-Anxiety Agents	0.114
Analgesics, Non-Narcotic	0.108
===== phenotype 8=================================================================
proportion of pts: 0.158270527568
lambda: 7227.19090435
----------------------------------------
Na	0.170
Range name na	0.163
Hypertensive disease	0.162
Neurotic, personality, nonpsychotic disorders	0.140
General symptoms	0.137
Symptoms involving respiratory system and other chest symptoms	0.116
Nutritional deficiencies	0.113
----------------------------------------
Antipyretics	0.128
Antidepressive Agents, Second-Generation	0.124
Serotonin Uptake Inhibitors	0.123
Anti-Ulcer Agents	0.121
Proton Pump Inhibitors	0.109
Anti-Anxiety Agents	0.103
Anticonvulsants	0.100
Hypnotics and Sedatives	0.100
Vitamins	0.093
===== phenotype 4=================================================================
proportion of pts: 0.142403808013
lambda: 6886.69293968
----------------------------------------
Hypertensive disease	0.159
Range name na	0.148
Arthropathies and related disorders	0.129
Rheumatism, excluding the back	0.119
Diabetes	0.116
Dorsopathies	0.113
General symptoms	0.111
Disorders of lipoid metabolism	0.105
----------------------------------------
Analgesics, Opioid	0.177
Narcotics	0.169
Voltage-Gated Sodium Channel Blockers	0.141
Anesthetics, Local	0.140
Antipruritics	0.134
Sodium Potassium Chloride Symporter Inhibitors	0.120
Antipsychotic Agents	0.117
===== phenotype 1=================================================================
proportion of pts: 0.15787385958
lambda: 6837.81931399
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.197
Disorders of the eye and adnexa	0.166
Hypertensive disease	0.155
Arthropathies and related disorders	0.132
Other inflammatory conditions of skin and subcutaneous tissue	0.125
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.118
Diseases of the ear and mastoid process	0.107
----------------------------------------
Antihypertensive Agents	0.127
Anti-Ulcer Agents	0.126
Anti-Arrhythmia Agents	0.120
Anti-Inflammatory Agents	0.117
Proton Pump Inhibitors	0.110
Cyclooxygenase Inhibitors	0.104
Anti-Inflammatory Agents, Non-Steroidal	0.100
Dermatologic Agents	0.098
Anti-Allergic Agents	0.098
===== phenotype 13=================================================================
proportion of pts: 0.17572391908
lambda: 6823.78109502
----------------------------------------
Arthropathies and related disorders	0.172
Hypertensive disease	0.168
Rheumatism, excluding the back	0.153
Dorsopathies	0.148
Disorders of lipoid metabolism	0.134
General symptoms	0.123
Range name na	0.102
----------------------------------------
Hypnotics and Sedatives	0.192
Anti-Anxiety Agents	0.185
Anticonvulsants	0.181
GABA Modulators	0.177
Analgesics, Non-Narcotic	0.136
Analgesics	0.129
===== phenotype 29=================================================================
proportion of pts: 0.121380404601
lambda: 6761.06627796
----------------------------------------
General symptoms	0.153
Hypertensive disease	0.148
Other forms of heart disease	0.129
Rheumatism, excluding the back	0.125
Disorders of lipoid metabolism	0.120
Anemias	0.118
Chronic obstructive pulmonary disease and allied conditions	0.109
Symptoms involving digestive system	0.097
----------------------------------------
Calcium Channel Blockers	0.139
Anticonvulsants	0.121
Analgesics	0.112
Excitatory Amino Acid Antagonists	0.111
Antiparkinson Agents	0.111
Anti-Anxiety Agents	0.109
Serotonin Uptake Inhibitors	0.103
Antimanic Agents	0.100
Bronchodilator Agents	0.093
===== phenotype 41=================================================================
proportion of pts: 0.130107100357
lambda: 6538.16617173
----------------------------------------
Hypertensive disease	0.177
Range name na	0.145
Disorders of lipoid metabolism	0.144
Gout	0.139
Rheumatism, excluding the back	0.137
Diabetes	0.130
Arthropathies and related disorders	0.127
----------------------------------------
Gout Suppressants	0.163
Antihypertensive Agents	0.138
Vasodilator Agents	0.138
Enzyme Inhibitors	0.127
Antimetabolites	0.121
Free Radical Scavengers	0.108
Antipyretics	0.108
Tubulin Modulators	0.098
===== phenotype 27=================================================================
proportion of pts: 0.17929393098
lambda: 6405.67131227
----------------------------------------
Disorders of lipoid metabolism	0.165
Hypertensive disease	0.162
Range name na	0.157
Arthropathies and related disorders	0.141
Other forms of heart disease	0.134
Rheumatism, excluding the back	0.126
Ischemic heart disease	0.115
----------------------------------------
Anti-Ulcer Agents	0.229
Proton Pump Inhibitors	0.217
Diuretics	0.194
Anti-Arrhythmia Agents	0.188
Sodium Chloride Symporter Inhibitors	0.173
===== phenotype 47=================================================================
proportion of pts: 0.147163823879
lambda: 6400.96318275
----------------------------------------
Hypertensive disease	0.167
Range name na	0.147
Symptoms involving respiratory system and other chest symptoms	0.137
Arthropathies and related disorders	0.127
Chronic obstructive pulmonary disease and allied conditions	0.118
Rheumatism, excluding the back	0.117
Symptoms involving skin and other integumentary tissue	0.094
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.093
----------------------------------------
Bronchodilator Agents	0.150
Adrenergic beta-2 Receptor Agonists	0.148
Anti-Bacterial Agents	0.147
Tocolytic Agents	0.138
Glucocorticoids	0.111
Sodium Potassium Chloride Symporter Inhibitors	0.108
Antimalarials	0.099
Anesthetics, Local	0.098
===== phenotype 7=================================================================
proportion of pts: 0.15787385958
lambda: 6289.06139796
----------------------------------------
Diabetes	0.189
Hypertensive disease	0.172
Range name na	0.157
Rheumatism, excluding the back	0.137
Arthropathies and related disorders	0.122
Other forms of heart disease	0.119
Dorsopathies	0.104
----------------------------------------
Cardiotonic Agents	0.160
Angiotensin-Converting Enzyme Inhibitors	0.155
Bone Density Conservation Agents	0.151
Hypoglycemic Agents	0.142
Vitamins	0.137
Analgesics, Non-Narcotic	0.131
Surface-Active Agents	0.124
===== phenotype 45=================================================================
proportion of pts: 0.148353827846
lambda: 6029.02478038
----------------------------------------
Other forms of heart disease	0.172
Hypertensive disease	0.165
Disorders of lipoid metabolism	0.149
Symptoms involving respiratory system and other chest symptoms	0.145
Range name na	0.141
Ischemic heart disease	0.128
General symptoms	0.099
----------------------------------------
Sodium Potassium Chloride Symporter Inhibitors	0.198
Adrenergic alpha-1 Receptor Antagonists	0.187
Diuretics	0.177
Adrenergic beta-Antagonists	0.166
Anti-Arrhythmia Agents	0.153
Enzyme Inhibitors	0.120
===== phenotype 36=================================================================
proportion of pts: 0.162237207457
lambda: 5955.07262462
----------------------------------------
Hypertensive disease	0.221
Disorders of lipoid metabolism	0.170
Range name na	0.157
Dorsopathies	0.133
Symptoms involving respiratory system and other chest symptoms	0.117
Disorders of thyroid gland	0.104
Nephritis, nephrotic syndrome, and nephrosis	0.097
----------------------------------------
Antioxidants	0.154
Vitamins	0.148
Bone Density Conservation Agents	0.144
Antiemetics	0.134
Histamine H1 Antagonists	0.114
Analgesics, Opioid	0.104
Narcotics	0.101
Glucocorticoids	0.100
===== phenotype 23=================================================================
proportion of pts: 0.143990479968
lambda: 5901.8622826
----------------------------------------
Hypertensive disease	0.219
Disorders of lipoid metabolism	0.187
Range name na	0.174
Diabetes	0.165
Arthropathies and related disorders	0.128
Rheumatism, excluding the back	0.127
----------------------------------------
Vitamin B Complex	0.159
Excitatory Amino Acid Antagonists	0.155
Anticonvulsants	0.152
Antiparkinson Agents	0.152
Antimanic Agents	0.141
Analgesics	0.141
Immunosuppressive Agents	0.100
===== phenotype 22=================================================================
proportion of pts: 0.151527171757
lambda: 5884.2041211
----------------------------------------
Hypertensive disease	0.161
Disorders of lipoid metabolism	0.150
Range name na	0.131
General symptoms	0.126
Nutritional deficiencies	0.112
Organic sleep disorders	0.112
Arthropathies and related disorders	0.106
Symptoms involving respiratory system and other chest symptoms	0.101
----------------------------------------
Bone Density Conservation Agents	0.183
Vitamins	0.156
Anti-Allergic Agents	0.146
Antidepressive Agents, Second-Generation	0.139
Histamine H1 Antagonists, Non-Sedating	0.129
Hypolipidemic Agents	0.124
Serotonin Uptake Inhibitors	0.123
===== phenotype 5=================================================================
proportion of pts: 0.152320507735
lambda: 5804.43266361
----------------------------------------
Symptoms involving digestive system	0.157
Hypertensive disease	0.157
Other symptoms involving abdomen and pelvis	0.149
Symptoms involving skin and other integumentary tissue	0.141
Other diseases of the upper respiratory tract	0.140
Symptoms involving head and neck	0.136
Other diseases of intestines and peritoneum	0.120
----------------------------------------
Antihypertensive Agents	0.169
Anti-Allergic Agents	0.149
Cyclooxygenase Inhibitors	0.145
Antipyretics	0.143
Anti-Inflammatory Agents, Non-Steroidal	0.140
Anti-Inflammatory Agents	0.137
Bronchodilator Agents	0.116
===== phenotype 26=================================================================
proportion of pts: 0.19714399048
lambda: 5537.85572242
----------------------------------------
Disorders of lipoid metabolism	0.200
Range name na	0.198
Disorders of the eye and adnexa	0.184
Hypertensive disease	0.175
Ischemic heart disease	0.144
Anemias	0.099
----------------------------------------
Anti-Inflammatory Agents	0.220
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.212
Anti-Allergic Agents	0.196
Hypolipidemic Agents	0.192
Anti-Bacterial Agents	0.181
===== phenotype 17=================================================================
proportion of pts: 0.114240380801
lambda: 5106.4095534
----------------------------------------
Other diseases of respiratory system	0.173
Symptoms involving respiratory system and other chest symptoms	0.165
Other forms of heart disease	0.165
Miscellaneous diagnostic and therapeutic procedures	0.162
Chronic obstructive pulmonary disease and allied conditions	0.124
Operations on the musculoskeletal system	0.106
Operations on the cardiovascular system	0.106
----------------------------------------
Antihypertensive Agents	0.177
Antipyretics	0.175
Anti-Inflammatory Agents, Non-Steroidal	0.168
Anti-Ulcer Agents	0.135
Anti-Allergic Agents	0.125
Analgesics, Non-Narcotic	0.121
Vitamins	0.099
===== phenotype 37=================================================================
proportion of pts: 0.118603728679
lambda: 5043.16160054
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.211
Hypertensive disease	0.192
Other forms of heart disease	0.142
Ischemic heart disease	0.125
Diseases of esophagus, stomach, and duodenum	0.120
Other symptoms involving abdomen and pelvis	0.110
Other diseases of intestines and peritoneum	0.099
----------------------------------------
Immunosuppressive Agents	0.149
Antirheumatic Agents	0.145
Enzyme Inhibitors	0.132
Dermatologic Agents	0.131
Antimetabolites, Antineoplastic	0.123
Folic Acid Antagonists	0.116
Nucleic Acid Synthesis Inhibitors	0.104
Abortifacient Agents, Nonsteroidal	0.100
===== phenotype 11=================================================================
proportion of pts: 0.172550575169
lambda: 5002.24220744
----------------------------------------
Hypertensive disease	0.168
Disorders of lipoid metabolism	0.152
Diseases of esophagus, stomach, and duodenum	0.128
Acute respiratory infections	0.123
Symptoms involving respiratory system and other chest symptoms	0.122
Diabetes	0.110
Other diseases of the upper respiratory tract	0.102
Organic sleep disorders	0.096
----------------------------------------
Anti-Ulcer Agents	0.270
Diuretics	0.270
Proton Pump Inhibitors	0.239
Sodium Chloride Symporter Inhibitors	0.221
===== phenotype 38=================================================================
proportion of pts: 0.148353827846
lambda: 4914.99409932
----------------------------------------
Disorders of lipoid metabolism	0.180
Diabetes	0.176
Hypertensive disease	0.165
Arthropathies and related disorders	0.135
Anemias	0.127
Nephritis, nephrotic syndrome, and nephrosis	0.126
Disorders of fluid, electrolyte, and acid-base balance	0.090
----------------------------------------
Anticholesteremic Agents	0.227
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.215
Antihypertensive Agents	0.208
Hypoglycemic Agents	0.177
Diuretics	0.174
===== phenotype 16=================================================================
proportion of pts: 0.146370487902
lambda: 4794.66395804
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.151
Dorsopathies	0.146
Acute respiratory infections	0.136
Symptoms involving respiratory system and other chest symptoms	0.129
Arthropathies and related disorders	0.117
Organic sleep disorders	0.109
Other diseases of skin and subcutaneous tissue	0.108
Rheumatism, excluding the back	0.105
----------------------------------------
Anti-Inflammatory Agents	0.221
Anti-Allergic Agents	0.170
Glucocorticoids	0.166
Anti-Bacterial Agents	0.162
Proton Pump Inhibitors	0.141
Serotonin Uptake Inhibitors	0.139
===== phenotype 39=================================================================
proportion of pts: 0.163823879413
lambda: 4550.09350511
----------------------------------------
Hypertensive disease	0.149
Disorders of lipoid metabolism	0.140
Range name na	0.137
Arthropathies and related disorders	0.122
General symptoms	0.121
Disorders of thyroid gland	0.115
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.111
Dorsopathies	0.106
----------------------------------------
Anti-Ulcer Agents	0.299
Proton Pump Inhibitors	0.261
Angiotensin-Converting Enzyme Inhibitors	0.237
Analgesics, Non-Narcotic	0.203
===== phenotype 21=================================================================
proportion of pts: 0.101547005157
lambda: 4342.42430844
----------------------------------------
Dorsopathies	0.167
Symptoms involving respiratory system and other chest symptoms	0.164
Disorders of the peripheral nervous system	0.157
Arthropathies and related disorders	0.149
Diabetes	0.132
Organic sleep disorders	0.128
Nephritis, nephrotic syndrome, and nephrosis	0.103
----------------------------------------
Anticonvulsants	0.157
Anti-Anxiety Agents	0.147
Analgesics	0.146
Excitatory Amino Acid Antagonists	0.144
Antiparkinson Agents	0.141
Antimanic Agents	0.141
Anti-Ulcer Agents	0.124
===== phenotype 49=================================================================
proportion of pts: 0.167393891313
lambda: 4098.46481371
----------------------------------------
Range name na	0.152
Hypertensive disease	0.128
Other diseases of urinary system	0.118
General symptoms	0.117
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.104
Symptoms involving urinary system	0.102
Rheumatism, excluding the back	0.097
Organic sleep disorders	0.092
Nonspecific findings on examination of blood	0.090
----------------------------------------
Anti-Allergic Agents	0.280
Dermatologic Agents	0.271
Immunosuppressive Agents	0.226
Enzyme Inhibitors	0.223
===== phenotype 30=================================================================
proportion of pts: 0.140420468068
lambda: 4094.05977041
----------------------------------------
Disorders of thyroid gland	0.263
Disorders of lipoid metabolism	0.226
Organic sleep disorders	0.184
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.178
Certain traumatic complications and unspecified injuries	0.150
----------------------------------------
Antihypertensive Agents	0.167
Cyclooxygenase Inhibitors	0.156
Antipyretics	0.153
Anti-Inflammatory Agents, Non-Steroidal	0.145
Vasodilator Agents	0.131
Calcium Channel Blockers	0.128
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.120
===== phenotype 32=================================================================
proportion of pts: 0.137247124157
lambda: 4057.17247868
----------------------------------------
Range name na	0.170
Other forms of heart disease	0.167
Ischemic heart disease	0.146
Cerebrovascular disease	0.142
Pain	0.139
Other diseases of the upper respiratory tract	0.125
Operations on the musculoskeletal system	0.110
----------------------------------------
Antihypertensive Agents	0.175
Anti-Anxiety Agents	0.156
Hypnotics and Sedatives	0.151
Anticonvulsants	0.144
Analgesics	0.134
Analgesics, Non-Narcotic	0.120
Platelet Aggregation Inhibitors	0.120
===== phenotype 19=================================================================
proportion of pts: 0.170567235224
lambda: 4004.75107077
----------------------------------------
Diabetes	0.202
Hypertensive disease	0.186
Disorders of lipoid metabolism	0.178
Rheumatism, excluding the back	0.116
Range name na	0.116
General symptoms	0.109
Dorsopathies	0.092
----------------------------------------
Vasodilator Agents	0.355
Hypoglycemic Agents	0.347
Hypolipidemic Agents	0.298
===== phenotype 34=================================================================
proportion of pts: 0.141213804046
lambda: 3537.19190783
----------------------------------------
Disorders of fluid, electrolyte, and acid-base balance	0.189
Dorsopathies	0.185
Anemias	0.170
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.163
Symptoms involving cardiovascular system	0.152
Nephritis, nephrotic syndrome, and nephrosis	0.141
----------------------------------------
Antihypertensive Agents	0.227
Antipyretics	0.220
Anti-Arrhythmia Agents	0.205
Diuretics	0.177
Calcium Channel Blockers	0.171
===== phenotype 14=================================================================
proportion of pts: 0.14319714399
lambda: 3514.7695287
----------------------------------------
General symptoms	0.173
Other diseases of urinary system	0.172
Symptoms involving urinary system	0.162
Rheumatism, excluding the back	0.160
Diabetes	0.128
Diseases of veins and lymphatics, and other diseases of circulatory system	0.104
Symptoms involving skin and other integumentary tissue	0.101
----------------------------------------
Anti-Ulcer Agents	0.306
Proton Pump Inhibitors	0.259
Anti-Bacterial Agents	0.228
Hypolipidemic Agents	0.206
===== phenotype 18=================================================================
proportion of pts: 0.144387147957
lambda: 3396.45180724
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.214
Disorders of thyroid gland	0.179
Other forms of heart disease	0.165
Cerebrovascular disease	0.157
Miscellaneous diagnostic and therapeutic procedures	0.148
Chronic obstructive pulmonary disease and allied conditions	0.137
----------------------------------------
Vasodilator Agents	0.250
Anticholesteremic Agents	0.211
Platelet Aggregation Inhibitors	0.195
Diuretics	0.177
Hypolipidemic Agents	0.168
===== phenotype 15=================================================================
proportion of pts: 0.138040460135
lambda: 2673.03249073
----------------------------------------
Diabetes	0.181
Rheumatism, excluding the back	0.146
Hypertensive disease	0.128
Mycoses	0.117
Dorsopathies	0.115
Other diseases of skin and subcutaneous tissue	0.110
Infections of skin and subcutaneous tissue	0.107
Symptoms involving digestive system	0.098
----------------------------------------
Anti-Arrhythmia Agents	0.374
Diuretics	0.354
Anti-Allergic Agents	0.272
===== phenotype 35=================================================================
proportion of pts: 0.137643792146
lambda: 2482.57790099
----------------------------------------
Hypertensive disease	0.192
Range name na	0.190
Arthropathies and related disorders	0.182
Rheumatism, excluding the back	0.166
General symptoms	0.163
Symptoms involving respiratory system and other chest symptoms	0.106
----------------------------------------
Anti-Inflammatory Agents	0.409
Glucocorticoids	0.323
Analgesics, Non-Narcotic	0.268
===== phenotype 40=================================================================
proportion of pts: 0.0975803252678
lambda: 1477.33980779
----------------------------------------
Other forms of heart disease	0.194
Ischemic heart disease	0.164
Other diseases of respiratory system	0.156
Range name na	0.131
Diseases of veins and lymphatics, and other diseases of circulatory system	0.131
Miscellaneous diagnostic and therapeutic procedures	0.125
Operations on the cardiovascular system	0.099
----------------------------------------
Analgesics, Opioid	0.515
Narcotics	0.485
===== phenotype 20=================================================================
proportion of pts: 0.147957159857
lambda: 1037.29844344
----------------------------------------
Other forms of heart disease	0.215
Hypertensive disease	0.209
Symptoms involving respiratory system and other chest symptoms	0.198
Other diseases of respiratory system	0.149
Acute respiratory infections	0.125
Symptoms involving digestive system	0.103
----------------------------------------
Anti-Bacterial Agents	1.000
